Red blood cell alloimmunization in sickle cell disease and in thalassaemia: Current status, future perspectives and potential role of molecular typing

Vox Sanguinis

Volumn 106, Issue 3, 2014, Pages 197-208

  Matteocci, A ^a   Pierelli, L ^a,b  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Blood groups; Genotyping; Immunohaematology; RBC antigens and antibodies; Transfusion strategy

Indexed keywords

ALLOIMMUNIZATION; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; DISEASE PREDISPOSITION; HUMAN; MOLECULAR DIAGNOSTICS; MOLECULAR TYPING; MORBIDITY; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; RED BLOOD CELL ALLOIMMUNIZATION; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA;

BLOOD GROUPS; GENOTYPING; IMMUNOHAEMATOLOGY; RBC ANTIGENS AND ANTIBODIES; TRANSFUSION STRATEGY;

ANEMIA, SICKLE CELL; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; FORECASTING; HUMANS; IMMUNIZATION, PASSIVE; ISOANTIBODIES; RISK FACTORS; THALASSEMIA;

EID: 84896546782     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12086     Document Type: Review

References (71)

1. Yazdanbakhsh Y, Ware RE, Noizet-Pirenne F: Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120:528-537
2. Avent ND: Large-scale blood group genotyping-clinical implications. Br J Haematol 2008; 144:3-13
3. Chou ST, Liem RI, Thompson AA: Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012; 159:394-404
4. Bolton-Maggs P, Cohen H, Watt A, et al.: Annual SHOT report 2011. Available at: http://www.shotuk.org
5. Fatalities reported following blood collection and transfusion. Annual Summary for Fiscal Year 2011. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM300764.pdf
6. The ISBT (International Society of Blood Transfusion) Site. Available at: http://isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology
7. Storry JR, Castilho L, Daniels G, et al.: International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011; 101:77-82
8. Daniels G, Reid ME: Blood groups: the past 50 years. Transfusion 2010; 50:281-289
9. Reid ME: Application and experience with PCR-based assays to predict blood group antigens. Transfus Med Hemother 2009; 36:168-178
10. Anstee DJ: Red cell genotyping and the future of pretransfusion testing. Blood 2009; 114:248-256
11. Vickinsky EP: The prevention and management of alloimmunization in sickle cell disease: The benefit of extended phenotypic matching of red blood cells. Immunohematology 2012; 28:20-23
12. Reid ME, Lomas-Francis C: The Blood Group Antigen Facts Book, 3rd edn. San Diego, CA, USA, Elsevier Academic Press, 2012
13. Hillyer CD, Shaz BH, Winkler AM, et al.: Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008; 22:117-132
14. Westhoff CM: The potential of blood group genotyping for transfusion medicine practice. Immunohematology 2008; 24:190-195
15. Morelati F, Arnaboldi P, Barocci F, et al.: Strategies for the transfusion of subjects with complex red cell immunization: the Bank of rare blood donors of the Region of Lombardy. Blood Transfus 2007; 5:217-226
16. Badjie KSW, Tauscher C, Van Buskirk C, et al.: Red blood cell phenotype matching for various ethnic groups. Immunohematology 2011; 27:12-18
17. AABB. Standards for Blood Banks and Transfusion Services, 27th edn. Bethesda, USA, AABB, 2011
18. Garratty G: What is a clinically significant antibody? ISBT Sci Ser 2012; 7:54-57
19. Poole J: What methods and process flow can assist in alloantibody identification? ISBT Sci Ser 2012; 7:58-61
20. Revelli N, Villa MA, Paccapelo C, et al.: The Immunohematology Reference Laboratory: the experience of the Policlinico Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan. Blood Transfus 2009; 7:94-99
21. Cheng CK, Lee CK, Lin CK: Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012; 52:2220-2224
22. Schonewille H, De Vries RRP, Brand A: Alloimmune response after additional red blood cell antigen challenge in immunized haematooncology patients. Transfusion 2009; 49:453-457
23. Sanz C, Nomdedeu M, Belkaid M, et al.: Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013; 53:710-715.
24. Bauer MP, Wiersun-Osselton J, Schipperus M, et al.: Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47:2066-2071
25. Schonewille H, van de Watering LMG, Brand A: Additional red blood cell alloantibodies after blood transfusion in a non hematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46:630-635
26. Tormey CA, Stack G: The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009; 49:505-512
27. Tormey CA, Stack G: Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy related antibodies. Blood 2009; 114:4279-4282
28. Giblett ER: A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961; 1:233-238
29. Higgins JM, Sloan RS: Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112:2546-2553
30. a immunization in a Southern European population. Transfusion 2009; 49:2412-2417
31. Hoppe C, Klitz W, Vichinsky E, et al.: HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 2009; 84:462-464
32. Noizat-Pirenne F, Tournamille C: Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011; 18:527-535
33. Chou ST, Westhoff CM: The role of molecular immunohematology in sickle cell disease. Transfus Apher Sci 2011; 44:73-79
34. Natakunda B: Red blood alloimmunization and antigen matching in sickle cell disease - the African perspective. ISBT Sci Ser 2012; 7:129-133
35. Bao W, Zhong H, Li X, et al.: Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major. Am J Hematol 2011; 86:1001-1006
36. Noizat-Pirenne F: Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease. Transfus Clin Biol 2012; 19:132-138
37. Campbell-Lee S: Red blood cell alloimmunization in sickle cell anemia: more questions than answers? Transfusion 2012; 52:214-216
38. LaSalle-Williams M, Nuss R, Le T, et al.: Extended red blood cell antigen matching for transfusion in sickle cell disease: a review of a 14 years experience from a single center. Transfusion 2011; 51:1732-1739
39. Batina-Agasa S, Dupont E, Kayembe T, et al.: Multiple transfusions for sickle cell disease in the Democratic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010; 17:254-259
40. Natukanda B, Schonewille H, Ndugwa C, et al.: Red blood cell alloimmunization in sickle cell disease in Uganda. Transfusion 2010; 50:20-25
41. Olujohungbe A, Hambleton I, Stephens L, et al.: Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001; 113:661-665
42. Ameen R, Al Shemmari S, Al-Bashir A: Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion 2009; 49:1649-1654
43. Vichinsky EP, Earles A, Johnson RA, et al.: Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322:1617-1621
44. Miller ST, Kim HY, Weiner DL, et al.: Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 2013; 54:704-709.
45. The Rhesus Site. Available at: http://www.uni-ulm.de/~wflegel/RH/
46. Flegel WA: Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011; 44:81-91
47. Scheunemann LP, Ataga KI: Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 2010; 339:266-269
48. Garratty G: Autoantibodies induced by blood transfusion. Transfusion 2004; 44:5-9
49. Castellino SM, Combs MR, Zimmerman SA, et al.: Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 1999; 104:189-194
50. Win N, New H, Lee E, et al.: Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008; 48:1231-1238
51. Saied DA, Kaddah AM, Badr Eldin RM, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. J Ped Hematol Oncol 2011; 33:409-414
52. El Danasoury AS, Eissa DG, Abdo RM, et al.: Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion 2012; 52:43-47
53. Sirchia G, Zanella A, Parravicini A, et al.: Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion 1985; 25:110-112
54. Spanos T, Karageorga M, Ladis V, et al.: Red cell alloantibodies in patients with thalassemia. Vox Sang 1990; 58:50-55
55. Singer ST, Wu V, Mignacca R, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000; 96:3369-3373
56. Ameen R, Al-Shemmari S, Al-Humood S, et al.: RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003; 43:1604-1610
57. Noor Haslina MN, Arrifin N, Illuni Hayati I, et al.: Red cell immunization in multiply transfused Malay thalassemic patients. Southest Asian J Trop Med Public Health 2006; 37:1015-1020
58. Azarkeivan A, Ansari S, Ahmadi MH, et al.: Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol 2011; 28:479-485
59. Gupta R, Singh DK, Singh B, et al.: Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci 2011; 45:167-170
60. Schonewille H, Brand A: Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005; 129:151-156
61. Thompson AA, Cunningham MJ, Singer ST, et al.: Red cell alloimmunization in a diverse population of transfused patients with thalassemia. Br J Haematol 2011; 153:121-128
62. Guirat-Dhouib N, Mezri M, Hmida H, et al.: High frequency of autoimmunization among transfusion-dependent Tunisian thalassemia patients. Transfus Apher Sci 2011; 45:199-202
63. Zimring JC, Spitalnik SL, Roback JD, et al.: Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007; 47:2189-2196
64. Fluit CR, Kunst VA, Drenthe-Schonk AM: Incidence of red cell antibodies after multiple blood transfusions. Transfusion 1990; 30:532-535
65. Zalpuri S, Zwaginga JJ, le Cessie S: Red blood cell alloimmunization and number of red blood cell transfusions. Vox Sang 2012; 102:144-149
66. Ribeiro KR, Guarnieri MH, da Costa DC, et al.: DNA array analysis for red cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97:147-152
67. Klapper E, Zhang Y, Figueroa P, et al.: Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010; 50:246-256
68. Rosse WF, Gallagher D, Kinney TR, et al.: Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76:1431-1437
69. Castro O, Sandler SG, Houston-Yu P, et al.: Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002; 42:684-690
70. Tahhan HR, Holbrook CT, Braddy LR, et al.: Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994; 34:562-569
71. Shander A, Hofmann A, Ozawa S, et al.: Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-765